Ravicti and Cough - a phase IV clinical study of FDA data

Summary:

Cough is reported as a side effect among people who take Ravicti (glycerol phenylbutyrate), especially for people who are male, 2-9 old, have been taking the drug for < 1 month also take Citrulline, and have Amino acid metabolism disorder.

The phase IV clinical study analyzes which people have Cough when taking Ravicti. It is created by eHealthMe based on reports of 1,197 people who have side effects when taking Ravicti from the FDA, and is updated regularly.

What is Ravicti?

Ravicti has active ingredients of glycerol phenylbutyrate. eHealthMe is studying from 1,197 Ravicti users. Check the latest studies of Ravicti.

What is Cough?

Cough is found to be associated with 3,049 drugs and 3,801 conditions by eHealthMe. Check the latest studies of Cough.

On Jul, 13, 2026

1,197 people reported to have side effects when taking Ravicti.
Among them, 23 people (1.92%) have Cough.

Among these 23 people:

How long have people been on Ravicti when they have Cough? *

What is the gender of people who have Cough when taking Ravicti? *

female: 47.62 %
male: 52.38 %

What is the age of people who have Cough when taking Ravicti? *

What are other drugs people take besides Ravicti? *

Epidiolex: 4 people, 17.39%
Neurontin: 4 people, 17.39%
Fycompa: 4 people, 17.39%
Vimpat: 4 people, 17.39%
Trileptal: 4 people, 17.39%
Reglan: 4 people, 17.39%
Cyproheptadine Hydrochloride: 4 people, 17.39%
Citrulline: 4 people, 17.39%
Ondansetron Hydrochloride: 3 people, 13.04%
Keppra: 2 people, 8.70%

What are other side effects people have besides Cough? *

Nausea And Vomiting: 13 people, 56.52%
Fatigue (feeling of tiredness): 5 people, 21.74%
Seizures (abnormal excessive or synchronous neuronal activity in the brain): 5 people, 21.74%
Drowsiness: 5 people, 21.74%
Abdominal Discomfort: 4 people, 17.39%
Regurgitation (expulsion of material): 4 people, 17.39%
Sedation: 4 people, 17.39%
Flatulence (flatus expelled through the anus): 4 people, 17.39%
Epilepsy (common and diverse set of chronic neurological disorders characterized by seizures): 4 people, 17.39%
Ammonia Increased: 4 people, 17.39%

What are the existing conditions these people have? *

Amino Acid Metabolism Disorder: 6 people, 26.09%
Seizures (abnormal excessive or synchronous neuronal activity in the brain): 4 people, 17.39%
Partial Seizures (seizures which affect only a part of the brain at onset): 4 people, 17.39%
Lennox-Gastaut Syndrome (epilepsy characterized by frequent seizures and different seizure types): 4 people, 17.39%
Epilepsy (common and diverse set of chronic neurological disorders characterized by seizures): 4 people, 17.39%
Argininosuccinate Synthetase Deficiency: 2 people, 8.70%
Carbamoyl Phosphate Synthetase Deficiency (metabolic disorder that causes ammonia to accumulate in the blood): 1 person, 4.35%
Attention Deficit Hyperactivity Disorder (a chronic condition including attention difficulty, hyperactivity, and impulsiveness): 1 person, 4.35%
Arginase Deficiency (inherited disorder that causes the amino acid arginine (a building block of proteins) and ammonia to accumulate gradually in the blood): 1 person, 4.35%

* Approximation only. Some reports may have incomplete information.

Do you take Ravicti and have Cough?

- Check whether Cough is associated with a drug or a condition
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously

Related studies:

Effectiveness of, long term effects of, and alternative drugs to Ravicti:

Ravicti (1,197 reports)

Cough treatments and more:

Cough (361,791 reports)

Browse all side effects of Ravicti:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all the drugs that are associated with Cough:

Cough (3,049 drugs)

Browse all the conditions that are associated with Cough:

Cough (3,801 conditions)

How the study uses the data?

The study uses data from the FDA. It is based on glycerol phenylbutyrate (the active ingredients of Ravicti) and Ravicti (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.